Smith & Nephew plc (SN.L)
-LSE 785.00 
9.50(1.20%) 11:37AM EDT
| Prev Close: | 794.50 |
|---|
| Open: | 780.50 |
|---|
| Bid: | 787.50 |
|---|
| Ask: | 788.00 |
|---|
| 1y Target Est: | 11.51 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 773.50 - 788.50 |
|---|
| 52wk Range: | 567.50 - 798.50 |
|---|
| Volume: | 1,457,575 |
|---|
| Avg Vol (3m): | 1,577,610 |
|---|
| Market Cap: | 7.10B |
|---|
| P/E (ttm): | 994.93 |
|---|
| EPS (ttm): | 0.79 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Headlines
- Profits Drop 4% at Smith & Nephewat Motley Fool(Thu, May 2)
- Q1 2013 Smith & Nephew Earnings Release - 02:00 am ETCCBN(Thu, May 2)
- Smith & Nephew Earnings Call scheduled for 3:30 am ET todayCCBN(Thu, May 2)
- Should You Buy Smith & Nephew Today?at Motley Fool(Fri, Apr 12)
- 3 More FTSE 100 Shares Going Ex-Dividend Next Weekat Motley Fool(Thu, Apr 11)
- Research shows that superbugs are killed by ACTICOAT™ silver-coated antimicrobial dressingsPR Newswire(Tue, Apr 9)
- Smith & Nephew releases new Modular Rail System in collaboration with Dr. Dror PaleyPR Newswire(Wed, Mar 20)
- Smith & Nephew launches natural-motion knee replacement at AAOS annual meetingPR Newswire(Tue, Mar 19)
- [$$] Smith & Nephew to Pursue Acquisitions to Fuel Growthat The Wall Street Journal(Fri, Mar 15)
- The Men and Women Who Run Smith and Nephewat Motley Fool(Sun, Feb 24)
- Smith & Nephew Raises Final Dividend by 50%at Motley Fool(Thu, Feb 7)
- Q4 & Full Year 2012 Smith & Nephew Earnings Call scheduled for 4:00 am ET todayCCBN(Thu, Feb 7)
- 5 FTSE 100 Shares for the Week Aheadat Motley Fool(Fri, Feb 1)
- Healthpoint Biotherapeutics Introduces Copay Assistance Program For Collagenase Santyl® OintmentPR Newswire(Fri, Feb 1)
- 3 Stocks I've Backed for the Reboundat Motley Fool(Sat, Jan 26)
Key Statistics
| Forward P/E (1 yr): | 9.35 |
|---|
| P/S (ttm): | 173.97 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.77 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.19 |
|---|
| Mean Recommendation*: | 2.8 |
|---|
| PEG Ratio (5 yr expected): | 2.48 |
|---|
Business Summary
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide.
View More